Baptist Health Herbert Wertheim Cancer Institute has reached a significant milestone in cancer care: the treatment of its 100th patient with CAR T-cell therapy. The achievement reflects the Institute’s commitment to advanced, specialized care and to expanding access to innovative options for patients with certain blood cancers.
How CAR T-Cell Therapy Works
CAR T-cell therapy is a form of immunotherapy that uses a patient’s own immune cells. Chimeric antigen receptor T-cell therapy modifies T cells, the white blood cells that destroy abnormal cells, to help the immune system detect and eliminate cancer.
The process typically unfolds in several steps:
- Blood is collected and the T cells are removed.
- The T cells are genetically altered with chimeric antigen receptors to strengthen their ability to detect cancer cells.
- The modified cells are grown in a laboratory until millions more are produced.
- The patient receives chemotherapy to help prepare the body for the new cells.
- The modified T cells are infused back into the patient’s bloodstream.
- The CAR T cells remain in the body long after infusion to help fight cancer if it returns.
This highly specialized treatment requires close coordination across multiple disciplines, from patient evaluation and cell collection to administration, monitoring, and ongoing care.
Team Achievement
The milestone comes under the leadership of Guenther Koehne, M.D., Ph.D., and recognizes the expertise, dedication, and collaboration of the teams supporting the CAR T-cell therapy and Blood and Marrow Transplantation (BMT) programs.
“Reaching our 100th CAR T-cell therapy patient is a moment to recognize the people behind every treatment. Each patient depends on a team that works together at every step, and I am deeply grateful to my team members. I am especially thankful to Drs. Linhares, Perez and Nahas for their efforts, skills and focus on providing specialized care following the CAR T-cell administration. This milestone belongs to the entire team, and to the patients and families who trusted us with their care,” said Dr. Koehne.
Built for Complex Care
Several strengths set the Institute’s program apart:
- Onsite cell processing. The Institute is one of the facilities in the area with the expertise and equipment onsite to complete the cell processing that forms the basis for immunotherapy. Its specially equipped laboratory is a certified Good Manufacturing Practice (GMP) facility.
- FACT accreditation. The Blood and Marrow Stem Cell Transplant Program is fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The accreditation confirms that the program meets the highest national and international standards for stem cell transplantation and cellular therapies, including CAR T-cell therapy.
- Memorial Sloan Kettering Cancer Alliance. The Institute is the only Florida facility that is a member of the alliance, which supports shared expertise and access to clinical trials.
- Dedicated inpatient care. Hope Tower at Baptist Health Baptist Hospital is home to the Institute’s inpatient bone marrow and immunotherapy programs, with private rooms designed for safety, comfort, and family presence.
Gratitude Across the Care Team
The Institute extends its appreciation to the physicians, advanced practice providers, nurses, transplant coordinators, cellular therapy specialists, pharmacists, and the many clinical and support team members whose contributions make these complex treatments possible.
Looking Ahead
Congratulations to Dr. Koehne and the entire CAR T-cell therapy and BMT team. Their commitment will continue to expand what patients and families across South Florida can access, from the first evaluation through every step of the treatment journey.
For more information on Cart T cell therapy offered at the Baptist Health Herbert Wertheim Cancer Institute, visit here.
